Consumption of benzodiazepines in the city of Belém-PA: comparative study of the first semester from 2020 to 2022
DOI:
https://doi.org/10.33448/rsd-v12i2.38919Keywords:
Benzodiazepines; Psychotropic drug; Consumption profile; Elderly.Abstract
Benzodiazepines (BZD's) psychoactive drugs that act as allosteric modulators (agonists) of the type A γ-aminobutyric acid (GABA-A) receptor in the central nervous system. In clinical practice, these drugs are often used and prescribed in the treatment of anxiety, insomnia and depression. Due to its various pharmacological actions, and prolonged use, it makes it among the five best-selling drugs in Brazil. The lack of information about the consequences of irrational use increases vulnerability to generating dependence. Therefore, this study sought to analyze the consumption and distribution of BZD’s in the city of Belém - Pará. An observational, longitudinal, and retrospective survey was used in this study, comparing the first half of the years 2020 to 2022, through the SNGPC system. The variables analyzed were amount of BZD’s per year, age group, sex and type of drug most dispensed. The results obtained in the study showed that a total of 33,068 BZD’s was dispensed, adding the first semesters of the years 2020 to 2022, the female gender showed a higher prevalence of consumption, as well as the age group that presented high consumption, was between 61 a 80 years old and the most prescribed BZD was Clonazepam.
References
Alves, T. M. (2017). Gênero e saúde mental: algumas interfaces. Working Paper. 2(3),1-22, e2182-7672.
Alvim, M. M., Cruz, D. T. D., Vieira, M. D. T., Bastos, R. R., & Leite, I. C. G. (2017). Prevalência e fatores associados ao uso de benzodiazepínicos em idosos
Auchewski, L., Andreatini, R., Galduróz, J. C. F. & Lacerda R. B. (2004). Avaliação da orientação médica sobre os efeitos colaterais de benzodiazepínicos. Revista. Brasileira. Psiquiatria. 26(1):24-31.
Balon R. (2018). The dawn of anxiolytics: Frank M. Berger, 1913-2008. The American journal of psychiatry, 165(12), 1531. https://doi.org/10.1176/appi.ajp.2008.08040552.
Barbosa, G. C. L. ., Ferraz, J. L. ., & Alves, L. A. . (2021). Impact of benzodiazepine medications on the quality of life of people with generalized anxiety disorder. Research, Society and Development, 10(15), e523101523202. https://doi.org/10.33448/rsd-v10i15.23202.
Batista, G. D. V.., Santos, G. D. da S. ., & Silva, W. C. da . (2022). Study of the use of Benzodiazepines in a public institution in Teresina-PI. Research, Society and Development, 11(1), e21611124839. https://doi.org/10.33448/rsd-v11i1.24839.
Bäuerle, A., Teufel, M., Musche, V., Weismüller, B., Kohler, H., Hetkamp, M., Dörrie, N., Schweda, A., & Skoda, E. M. (2020). Increased generalized anxiety, depression and distress during the COVID-19 pandemic: a cross-sectional study in Germany. Journal of public health (Oxford, England), 42(4), 672–678. https://doi.org/10.1093/pubmed/fdaa106.
Bezerra, D. S., Bonzi, A. R. B., Silva, G. R., Lima, A. K. B. S. (2018). Mulheres e o uso de benzodiazepínicos: uma revisão integrativa. 18 (2), e2447-213. DOI: 10.29327/213319.18.3-19.
Borges, T. L., Miasso, A. I.,Vedana, K. G. G., Filho, P. C. P. T. & Hegadoren, K. M. (2015). Prevalência do uso de psicotrópicos e fatores associados na atenção primária à saúde. Acta Paulista de Enfermagem, 28(4), 344-349. https://doi.org/10.1590/1982-0194201500058.
Brunton, L. L., Hilal-Dandan, R., & Knollmann, B. C. (2018). As Bases Farmacológicas da Terapêutica de Goodman e Gilman-13. Artmed Editora, 417.
Calcaterra, N. E., & Barrow, J. C. (2014). Classics in chemical neuroscience: diazepam (valium). ACS chemical neuroscience, 5(4), 253–260. https://doi.org/10.1021/cn5000056.
Campo-Soria, C., Chang, Y., & Weiss, D. S. (2006). Mechanism of action of benzodiazepines on GABAA receptors. British journal of pharmacology, 148(7), 984–990. https://doi.org/10.1038/sj.bjp.0706796.
Castro, R. L. de, Zanin, L., Moraes, L. A., Ramacciato, J. C., Bergamaschi, C. de C., & Flório, F. M. (2022). Analysis of dispensation of opioids in Brazil: 2014-2018. Research, Society and Development, 11(3), e9911326240. https://doi.org/10.33448/rsd-v11i3.26240.
CEBRID. (2010). Centro Brasileiro de Informações sobre Drogas Psicotrópicas: UNIFESP - Universidade Federal de São Paulo 2010. SENAD - Secretaria Nacional de Políticas sobre Drogas, Brasília – SENAD. 2010. 503. Carlini, E. A., Noto, A. R., Sanchez, Z. V. D. M., Carlini, C. M. A., Locatelli, D. P., e cols. (2005). Levantamento Domiciliar sobre o Uso de Drogas Psicotrópicas no Brasil. São Paulo: CEBRID/UNIFES; 2002. VI Levantamento Nacional sobre o Consumo de Drogas Psicotrópicas entre Estudantes do Ensino Fundamental e Médio das Redes Pública e Privada de Ensino nas 27 Capitais Brasileiras.
Chaves, T. do S. S., & Bellei, N. C. J. (2020). SARS-COV-2, o novo Coronavírus: uma reflexão sobre a Saúde Única (One Health) e a importância da medicina de viagem na emergência de novos patógenos. Revista De Medicina, 99(1), i-iv. https://doi.org/10.11606/issn.1679-9836.v99i1pi-iv.
Chouinard, G., Young, S. N., & Annable, L. (1983). Antimanic effect of clonazepam. Biological psychiatry, 18(4), 451–466.
Coronavirus disease (COVID-19) pandemic (2021). https://www.who.int/emergencies/diseases/novelcoronavirus-2019.
da comunidade. Revista Brasileira de Geriatria e Gerontologia, 20, 463-473.
Díaz-Gutiérrez, M. J., Martínez-Cengotitabengoa, M., de Adana, E. S., Cano, A. I., Martínez-Cengotitabengoa, M. T., Besga, A., ... & González-Pinto, A. (2017). Relationship between the use of benzodiazepines and falls in older adults: a systematic review. Maturitas, 101, 17-22.
Drug Enforcement Administration. (2017). Drugs of abuse: a DEA resource guide. Drug Enforcement Administration, US Department of Justice.
Edinoff, A. N., Fort, J. M., Singh, C., Wagner, S. E., Rodriguez, J. R., Johnson, C. A., Cornett, E. M., Murnane, K. S., Kaye, A. M., & Kaye, A. D. (2022). Alternative Options for Complex, Recurrent Pain States Using Cannabinoids, Psilocybin, and Ketamine: A Narrative Review of Clinical.
Evidence. Neurology International, 14(2), 423–436. https://doi.org/10.3390/neurolint14020035.
Firmino, K. F., De Abreu, M. H. N. G., Perini, E., & Magalhães, S. M. S. (2011). Fatores associados ao uso de benzodiazepínicos no serviço municipal de saúde da cidade de Coronel Fabriciano, Minas Gerais, Brasil. Cadernos de Saúde Pública, 27 (6),1223-1232. https://doi.org/10.1590/S0102311X2011000600019.
Fox, C., Liu, H., Kaye, A. D., Manchikanti, L., Trescot, A. M., Christo, P. J., & Falco, F. J. R. (2011). Clinical aspects of pain medicine and interventional pain management: a comprehensive review. Paducah, KY: ASIP Publishing. Antianxiety agents, 543-552.
Golan, D. E., Tashjian, A. H., Armstrong, E. J. & Armstrong, A.W. (2009). Princípios de Farmacologia: A Base Fisiopatológica da Farmacoterapia. 2ª ed. Rio de Janeiro: Guanabara Koogan.
Griffin III, C. E., 3rd, Kaye, A. M., Bueno, F. R., & Kaye, A. D. (2013). Benzodiazepine pharmacology and central nervous system-mediated effects. The Ochsner journal, 13(2), 214–223.
Guilland, R., Knapik, Klokner J., Klokner, S., G., M., Carlotto, P., A., C., Trevisan, K., R., R., Cieslak, S., Z., Francisco, D., R., M & Cruz, Roberto Moraes. (2021). Sintomas de depressão e ansiedade em trabalhadores durante a pandemia da COVID-19. Revista Psicologia Organizações e Trabalho, 21(4), 1721-1730. https://dx.doi.org/10.5935/rpot/2021.4.22625.
Hamra, A., Barbosa Ribeiro, M., & Ferreira Miguel, O. (2007). Correlação entre fratura por queda em idosos e uso prévio de medicamentos. Acta Ortopédica Brasileira, 15(3), 143-145.
Heel, C., Brogden, R.N., Speight, T.M., & Avery, G. S. (1981). Temazepam: A Review of its Pharmacological Properties and Therapeutic Efficacy as an Hypnotic. Drugs, 21 (5), 321-340.
Hillestad, L., Hansen, T., Melsom, H., & Drivenes, A. (1974). Diazepam metabolism in normal man. I. Serum concentrations and clinical effects after intravenous, intramuscular, and oral administration. Clinical pharmacology and therapeutics, 16(3), 479–484. https://doi.org/10.13037/ras.vol15n52.4558.
Huppertz, L. M, Bisel, F., Westphal, F., Franz, F., Auwärter, V., & Moosmann, B. (2015). Characterization of the four designer benzodiazepines clonazolam, deschloroetizolam, flubromazolam, and meclonazepam, and identification of their in vitro metabolites. Forensic Toxicol 33, 388–395 (2015). https://doi.org/10.1007/s11419-015-0277-6.
Kantorski, L. P., Treichel , C. A. S., Santos, C. G., Menezes, E. S., Almeida, M. D., Poliana Farias Alves, P. F., Jardim, V. M. R. (2020).. Prevalence of psychotropic drug use and conformity of therapeutic dose among mental health users. Revista Brasileira de Enfermagem. 74(6):e20200679. https://doi.org/10.1590/0034-7167-2020-0679.
Leigh-Hunt, N., Bagguley, D., Bash, K., Turner, V., Turnbull, S., Valtorta, N., & Caan, W. (2017). An overview of systematic reviews on the public health consequences of social isolation and loneliness. Public health, 152, 157–171. https://doi.org/10.1016/j.puhe.2017.07.035.
Lin, L. Y., Wang, J., Ou-Yang, X. Y., Miao, Q., Chen, R., Liang, F. X., Zhang, Y. P., Tang, Q., & Wang, T. (2021). The immediate impact of the 2019 novel coronavirus (COVID-19) outbreak on subjective sleep status. Sleep medicine, 77, 348–354. https://doi.org/10.1016/j.sleep.2020.05.018.
Lopes, J. M., Nascimento, F. B. R. do., Braga, A. O., Silva Junior, A. V. de B., Araujo, S. V. de L., & Leite, Y. K. C. (2022). Uso elevado de psicofármacos durante a pandemia da COVID-19: uma análise a partir de levantamentos epidemiológicos. Research, Society and Development, 11(8), e47511831180. https://doi.org/10.33448/rsd-v11i8.31180.
Manso, M. E. G., Biffi, E. C A. & Gerardi, T. J. (2015). Prescrição inadequada de medicamentos a idosos portadores de doenças crônicas em um plano de saúde no município de São Paulo, Brasil. Revista Brasileira de Geriatria e Gerontologia, 18(1), 151-164. https://doi.org/10.1590/1809-9823.2015.14056.
Moreira, P., & Borja, A. (2018). Benzodiazepínicos: uso e abuso em pacientes idosos. Centro de Pós-Graduação, Pesquisa e Extensão Oswaldo Cruz, Rio de Janeiro.
Mosfiak, M., Stolf Brzozowski, F., & Cichota, L. C. (2020). Análise do consumo de benzodiazepínicos em um município do norte do Rio Grande do Sul, Brasil. Revista De Saúde Coletiva Da UEFS, 10(1), 49–57. https://doi.org/10.13102/rscdauefs.v10i1.5214.
Naloto, D. C. C., Lopes, F. C., Barberato Filho, S., Lopes, L. C., Del Fiol, F. D. S., & Bergamaschi, C. D. C. (2016). Prescription of benzodiazepines for adults and older adults from a mental health clinic. Ciência & saúde coletiva, 21, 1267-1276.
Nardi, A. E., & Perna, G. (2006). Clonazepam in the treatment of psychiatric disorders: an update. International clinical psychopharmacology, 21(3), 131–142. https://doi.org/10.1097/01.yic.0000194379.65460.a6.
OECD. (2020). The territorial impact of COVID-19: Managing the crisis across levels of government (2020). https://www.oecd.org/coronavirus/policy-responses/the-territorial-impact-of-covid19-managing-the-crisis-across-level.
Oliveira, A. L. M. L., Nascimento, M., M., G., Costa, E. C., Firmo, J., O. A., Costa, M. F., L. & Filho, A. I. L. (2020). Aumento da utilização de benzodiazepínicos entre idosos mais velhos: Projeto Bambuí. Revista Brasileira de Epidemiologia. v. 23. https://doi.org/10.1590/1980-549720200029.
Organização Mundial da Saúde . (2006). Trabalhando juntos pela saúde: relatório mundial de saúde 2006: resumos de políticas. Organização Mundial da Saúde. https://apps.who.int/iris/handle/10665/43471
Organização Mundial de Saúde. (OMS). Coronavirus disease (COVID-19) pandemic (2021). https://www.who.int/emergencies/diseases/novelcoronavirus-2019.
Passos Neto, C. D. N., Leite, E. S., Martins, A. K. L., Oliveira, F., B., Castro, A. P. & Pimenta, C. J. L. (2020). Consumo de benzodiazepínicos por idosos usuários da Estratégia Saúde da Família. Revista Online de Pesquisa Cuidado é Fundamental. 12:883-889. http://dx.doi.org/ 0.9789/2175-5361.rpcfo.v12.7900
Penha, I. N. S., Santos, A. L. M., Marinho, A. C. H. F. & Alves, L. A. (2021). The use of controlled medications during the Covid-19 pandemic observed in a drugstore in the southwestern region of Bahia. Research, Society and Development, 10(16), e246101623752. https://doi.org/10.33448/rsd-v10i16.23752.
Pietrabissa, G., & Simpson, S. G. (2020). Psychological Consequences of Social Isolation During COVID-19 Outbreak. Frontiers in psychology, 11, 2201. https://doi.org/10.3389/fpsyg.2020.0220.
Poyares, D., Guilleminault, C., Ohayon, M. M., & Tufik, S. (2004). Chronic benzodiazepine usage and withdrawal in insomnia patients. Journal of psychiatric research, 38(3), 327–334. https://doi.org/10.1016/j.jpsychires.2003.10.003.
Rogers, J. P., Chesney, E., Oliver, D., Pollak, T. A., McGuire, P., Fusar-Poli, P., Zandi, M. S., Lewis, G., & David, A. S. (2020). Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. The lancet. Psychiatry, 7(7), 611–627. https://doi.org/10.1016/S2215-0366(20)30203-0.
Sarangi, A., McMahon, T., & Gude, J. (2021). Benzodiazepine Misuse: An Epidemic Within a Pandemic. Cureus, 13(6), e15816. https://doi.org/10.7759/cureus.15816.
Silva, P. A., Almeida, L. Y. & Souza, J. (2019). O uso de benzodiazepínicos em mulheres atendidas pela Estratégia de Saúde da Família em um município do interior paulista. Revista Escola de Enfermagem de Ribeirão Preto, Universidade de São Paulo. 53 03419. https://doi.org/10.1590/S1980-220X2017038903419.
Souto, S. M. T., Podestá, M. H. M. C., Souza, W. A. & Almeida, G. G. (2020). Qualidade de vida de idosos usuários de benzodiazepínicos. Revista de Atenção à Saúde, 15, (52), p. 96-101.
Stephens, D. N., & King, S. L. (2013). Biological Research on Addiction || Neuropharmacology of Benzodiazepines. 2, 605–614.
The territorial impact of COVID-19: Managing the crisis across levels of government (2020). Accessed: November 10, 2020: https://www.oecd.org/coronavirus/policy-responses/the-territorial-impact-of-covid19-managing-the-crisis-across-level.
Twenge, J. M., & Joiner, T. E. (2020). U.S. Census Bureau-assessed prevalence of anxiety and depressive symptoms in 2019 and during the 2020 COVID-19 pandemic. Depression and anxiety, 37(10), 954–956. https://doi.org/10.1002/da.23077.
United Nations Office on Drugs and Crime. (2018). Understanding the synthetic drug market: The NPS factor. Global Smart Update, 19, 1-12.
Vahratian, A., Blumberg, S. J., Terlizzi, E. P., & Schiller, J. S. (2021). Symptoms of Anxiety or Depressive Disorder and Use of Mental Health Care Among Adults During the COVID-19 Pandemic - United States, August 2020-February 2021. MMWR. Morbidity and mortality weekly report, 70(13), 490–494. https://doi.org/10.15585/mmwr.mm7013e2.
Verdoux, H., Lagnaoui, R., & Begaud, B. (2005). Is benzodiazepine use a risk factor for cognitive decline and dementia? A literature review of epidemiological studies. Psychological Medicine, 35(3), 307-315. doi:10.1017/S0033291704003897.
Veronez, V. A., Saravalli, M. I., Presumido, J., Marques, L. B. & Silva, P; S. C. (2022). Estudo sobre o uso de benzodiazepínicos no município de Adamantina. Brazilian Journal of Health Review. 5 (4), e 13618-13631. DOI:10.34119/bjhrv5n4-136.
Walters, R. J., Hadley, S. H., Morris, K. D., & Amin, J. (2000). Benzodiazepines act on GABAA receptors via two distinct and separable mechanisms. Nature neuroscience, 3(12), 1274–1281. https://doi.org/10.1038/81800.
Whalen, K.; Finkel, R. Panavelil, T. & Langeloh, A. (2016). Ansiolíticos e hipnóticos in Farmacologia ilustrada. (pp. 121-135) Porto Alegre.
WHO-World Health Organization. (2006). The world health report 2006: working together for health. World Health Organization. https://www.who.int/health-topics/drugs-psychoactive#tab=tab_3.
Wick, J. Y. (2013). The history of benzodiazepines. The Consultant Pharmacist, 28 (9), 538-548.
Zapata, F., Matey, J. M., Montalvo, G., C. & Ruiz, C., G. (2020). Chemical classification of new psychoactive substances (NPS), Microchemical Journal. https://doi.org/10.1016/j.microc.2020.105877.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Rangele Ferreira da Silva Reis; Isis de Oliveira Kosmiscky; Maria Cristiane Oliveira; Francilene Nascimento de Miranda; Robson José da Silva Cruz; Thays Chaves Araújo; Milana Rodrigues Vieira; Ester Cristina Silva dos Santos; Edson Bruno Campos Paiva; Sabrina de Carvalho Cartágenes
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
